Appropriate repair of DNA lesions and the inhibition of DNA repair activities at telomeres are crucial to prevent genomic instability. By fuelling the generation of genetic alterations and by compromising cell viability, genomic instability is a driving force in cancer and ageing 1,2 . Here we identify MAD2L2 (also known as MAD2B or REV7) through functional genetic screening as a novel factor controlling DNA repair activities at mammalian telomeres. We show that MAD2L2 accumulates at uncapped telomeres and promotes non-homologous end-joining (NHEJ)-mediated fusion of deprotected chromosome ends and genomic instability. MAD2L2 depletion causes elongated 39 telomeric overhangs, indicating that MAD2L2 inhibits 59 end resection. End resection blocks NHEJ while committing to homologydirected repair, and is under the control of 53BP1, RIF1 and PTIP 3 . Consistent with MAD2L2 promoting NHEJ-mediated telomere fusion by inhibiting 59 end resection, knockdown of the nucleases CTIP or EXO1 partially restores telomere-driven genomic instability in MAD2L2-depleted cells. Control of DNA repair by MAD2L2 is not limited to telomeres. MAD2L2 also accumulates and inhibits end resection at irradiation-induced DNA double-strand breaks and promotes end-joining of DNA double-strand breaks in several settings, including during immunoglobulin class switch recombination. These activities of MAD2L2 depend on ATM kinase activity, RNF8, RNF168, 53BP1 and RIF1, but not on PTIP, REV1 and REV3, the latter two acting with MAD2L2 in translesion synthesis 4 . Together, our data establish MAD2L2 as a crucial contributor to the control of DNA repair activity by 53BP1 that promotes NHEJ by inhibiting 59 end resection downstream of RIF1.
Appropriate repair of DNA lesions and the inhibition of DNA repair activities at telomeres are crucial to prevent genomic instability. By fuelling the generation of genetic alterations and by compromising cell viability, genomic instability is a driving force in cancer and ageing 1, 2 . Here we identify MAD2L2 (also known as MAD2B or REV7) through functional genetic screening as a novel factor controlling DNA repair activities at mammalian telomeres. We show that MAD2L2 accumulates at uncapped telomeres and promotes non-homologous end-joining (NHEJ)-mediated fusion of deprotected chromosome ends and genomic instability. MAD2L2 depletion causes elongated 39 telomeric overhangs, indicating that MAD2L2 inhibits 59 end resection. End resection blocks NHEJ while committing to homologydirected repair, and is under the control of 53BP1, RIF1 and PTIP 3 . Consistent with MAD2L2 promoting NHEJ-mediated telomere fusion by inhibiting 59 end resection, knockdown of the nucleases CTIP or EXO1 partially restores telomere-driven genomic instability in MAD2L2-depleted cells. Control of DNA repair by MAD2L2 is not limited to telomeres. MAD2L2 also accumulates and inhibits end resection at irradiation-induced DNA double-strand breaks and promotes end-joining of DNA double-strand breaks in several settings, including during immunoglobulin class switch recombination. These activities of MAD2L2 depend on ATM kinase activity, RNF8, RNF168, 53BP1 and RIF1, but not on PTIP, REV1 and REV3, the latter two acting with MAD2L2 in translesion synthesis 4 . Together, our data establish MAD2L2 as a crucial contributor to the control of DNA repair activity by 53BP1 that promotes NHEJ by inhibiting 59 end resection downstream of RIF1.
As the processes underlying telomere-driven genomic instability are not completely understood, we performed a functional genetic screen to identify telomere-induced genomic instability regulators (TIGIRs). The TIGIR screen relies on well-controlled reversible inactivation of telomere component TRF2 by expressing temperature-sensitive TRF2(Ile468Ala) (TRF2ts) in Trf2 2/2 p53 2/2 (also known as Terf2 2/2 Trp53 2/2 ) mouse embryo fibroblasts (MEFs) 5 . At the permissive temperature (32 uC), the TRF2ts MEFs have intact TRF2-mediated telomere protection, but at non-permissive temperatures (37-39 uC) TRF2ts is inactive, causing ATM kinase activation, accumulation of DNA damage response (DDR) proteins and NHEJ-dependent ligation at chromosome ends 5 . In the TIGIR screen ( Fig. 1a) , prolonged TRF2-inactivation causes TRF2ts cells to irreversibly arrest or die owing to severe chromosome end fusion that drives cells into genomic crisis [6] [7] [8] . However, diminished telomere fusion, such as with RNF8 or DNA ligase IV deficiency, allows survival and proliferation despite telomere uncapping [9] [10] [11] .
In a triplicate TIGIR screen we assayed 1,976 short hairpin RNAs (shRNAs), targeting 391 genes linked to DDR, for shRNAs that allow TRF2ts cells to survive 12 days of telomere uncapping. Among shRNA targets substantially enriched in at least two out of three screens were several factors previously shown to control telomere fusion (Extended Data Fig. 1a, b ), including ATM, NBS1, RAD50, 53BP1 and RNF8 (refs 11-15) . Remarkably, the most prominent screen hit, also independently recovered in a genome-wide TIGIR screen (our unpublished results), was MAD2L2 (Extended Data Fig. 1a, b ). MAD2L2 has no known function at telomeres but acts as a non-catalytic interaction partner of REV1 and REV3 in translesion synthesis 4 . Knockdown of Mad2l2 with independent shRNAs markedly increased the survival of TRF2ts MEFs subjected to telomere uncapping, which was abolished by complementation with exogenous shRNA-resistant human MAD2L2 (Fig. 1b, c and Extended Data Fig. 1c-f ). Interestingly, we failed to detect a similar activity for REV1 or REV3 (Extended Data Fig. 1g -i).
Indeed, enhanced survival of MAD2L2-depleted cells after long-term TRF2 inactivation was due to diminished telomere fusion. Mad2l2 knockdown significantly reduced telomere fusions, which was prevented by complementation with exogenous MAD2L2 ( Fig. 2a and Extended Data Fig. 2a ). Telomeres end with a single-stranded 39 G-overhang that undergoes DNA-ligase-IV/NHEJ-dependent degradation after loss of TRF2-mediated telomere protection 9, 10 . Analysis of telomeric 39 G-overhangs showed that MAD2L2 depletion prevents overhang loss at 48 h of TRF2 inactivation, further confirming that MAD2L2 is essential for efficient processing of deprotected telomeres by NHEJ ( Fig. 2b and Extended Data Fig. 2b ). The defect in NHEJ-mediated telomere fusion in Mad2l2-knockdown cells was not explained by changes in cellcycle progression (Fig. 1b, 32 uC panels, and Extended Data Figs 1e and 2c, d). Moreover, MAD2L2 is essential for sister-telomere fusion after activation of DNA repair in mitosis 16 (Extended Data Fig. 2e ). In line in telomere-driven genomic instability. a, Outline of TIGIR screen to identify factors controlling telomere-driven genomic instability. d, day. b, Survival assays of TRF2ts MEFs infected with control shRNA (sh) or Mad2l2 shRNAs (sh1-sh4), stained after growth as indicated. c, Growth curves at 39 uC of TRF2ts cells transduced with control or Mad2l2 sh4 shRNAs and complemented with empty control or RNA interference (RNAi)-resistant Flag-MAD2L2 RR (data are mean 6 s.d. from quadruplicate technical replicates). with MAD2L2 promoting telomere fusion, chromosomal rearrangement and mis-segregation [6] [7] [8] , MAD2L2 depletion prevented tetraploidy and aneuploidy after telomere uncapping ( Fig. 2c and Extended Data Fig. 2f ).
To address whether the requirement of MAD2L2 for NHEJ extends beyond telomeres, we investigated whether MAD2L2 depletion affects end-joining in other settings. Knockdown of human MAD2L2 considerably impaired NHEJ-mediated repair of I-Sce1-induced DNA doublestrand breaks (DSBs), NHEJ-mediated random plasmid integration, resolution of irradiation-induced DSBs in homology-directed repair (HDR)-deficient cells and clonogenic survival after irradiation, similar to depletion of the NHEJ-promoting factors 53BP1 and RIF1 (Fig. 2d , e and Extended Data Fig. 3a-e ). Moreover, class switch recombination (CSR), a physiological process depending on joining of DNA DSBs by NHEJ 17 , was substantially impaired in MAD2L2-depleted cells ( Fig. 2f and Extended Data Fig. 3f -i). This CSR defect was not due to defects in cell proliferation or expression of Aid (also known as Aicda) messenger RNA, IgM and IgA germ-line transcripts. Thus, MAD2L2 promotes NHEJ-mediated repair in several contexts.
To investigate how MAD2L2 promotes NHEJ, we first addressed its localization. MAD2L2 accumulated both at TRF2-deprotected telomeres and irradiation-induced DSBs (Fig. 3a) , implying a direct activity of MAD2L2 at these sites. Next we examined activation of the DDR. At 3, 6 and 12 h of TRF2 inactivation, both control and MAD2L2-depleted cells activated ATM, phosphorylated H2AX, KAP1 and CHK2 (cH2AX, p-KAP1 and p-CHK2, respectively), and formed p-ATM and cH2AX foci to a similar extent (Fig. 3b , c and Extended Data Fig. 4a, b ). Moreover, accumulation of 53BP1, RIF1 and PTIP to uncapped telomeres, as well as irradiation-induced DSBs, was unperturbed in MAD2L2depleted cells ( Fig. 3c and Extended Data Fig. 4a -c). Thus, MAD2L2 is not required for recognition of uncapped telomeres or DSBs as damage, nor for initiation of DDR signalling. However, probably reflecting aberrant processing of deprotected telomeres, we noticed increased DDR signalling at 24 and 48 h of TRF2 inactivation in MAD2L2-depleted cells, 
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visible as increased H2AX and KAP1 phosphorylation, and H2AX ubiquitylation ( Fig. 3b ). Next we examined the terminal structure of telomeres in more detail. Analysis of 39 single-stranded G-overhangs at 6 and 12 h of TRF2 inactivation revealed that in the absence of MAD2L2, telomeres gain considerably longer 39 single-stranded overhangs. At 12 h, Mad2l2knockdown cells contained 2.5-fold higher, 39-exonuclease sensitive overhang signals than control cells without uncapping, and nearly sixfold higher overhang signals than control cells at 12 h of telomere uncapping (Fig. 3d , e and Extended Data Fig. 5a ). Overhang increase upon MAD2L2 depletion was observed in both wild-type and DNA-ligase-IV-deficient TRF2ts cells (Extended Data Fig. 5b-d ), indicating it is not a passive consequence of lack of NHEJ-mediated overhang degradation, but represents an active role of MAD2L2 in inhibiting 59 end resection. 59 DNA end resection is a powerful obstruction to NHEJ by creating DNA ends unsuitable for ligation 18 , explaining why MAD2L2 depletion impairs NHEJ-mediated repair.
59 end resection involves the combined activities of CTIP, MRN, EXO1, BLM and DNA2, and is blocked by 53BP1 and its interaction partners RIF1 and PTIP 3, 13, [19] [20] [21] [22] [23] [24] . In line with MAD2L2 promoting NHEJ by impeding 59 end resection, co-depletion of CTIP or EXO1 with MAD2L2 partially reversed the increased survival of Mad2l2-knockdown cells undergoing prolonged telomere uncapping ( Fig. 3f and Extended Data Fig. 5e -h). Moreover, consistent with the generation of longer single-stranded overhangs that block NHEJ and prime for HDR, Mad2l2knockdown cells showed increased phosphorylation of the ATR target CHK1 and of the single-stranded DNA-binding protein RPA (Fig. 3g ). In addition, MAD2L2-depleted cells showed increased HDR at telomeres by increased telomere sister-chromatid exchanges (TSCE; Extended Data Fig. 6a ).
Because the effects of MAD2L2 depletion on end resection, telomere fusion and CSR resemble those of 53BP1, RIF1 and, to a certain extent, PTIP inactivation 3,13,19-24 , we asked whether MAD2L2 is epistatic with 53BP1, RIF1 or PTIP. Similarly, we addressed the requirement of REV1 and REV3 for the ability of MAD2L2 to control end resection and telomere fusion. Unlike in wild-type or PTIP-deficient MEFs, MAD2L2 depletion did not reduce fusion of TRF2-deprotected telomeres in 53BP1-or RIF1-deficient MEFs ( Fig. 4a and Extended Data Fig. 6b-e ). However, MAD2L2(Leu186Ala) and MAD2L2(Cys70Arg), defective in REV1 or REV3 interaction, respectively 25, 26 , were still capable of promoting telomere fusion and telomere-driven genomic instability ( Fig. 4b and Extended Data Fig. 7a , g, i). Moreover, MAD2L2 depletion resulted in increased RPA phosphorylation after irradiation in wild-type, Ptip 2/2 , Rev1 2/2 or Rev3 2/2 MEFs, but not in 53bp1 2/2 (also known as Trp53bp1 2/2 ) or Rif1 2/2 MEFs (Fig. 4c ). This indicates that MAD2L2 controls end resection and fusion of deprotected telomeres in a 53BP1and RIF1-dependent, but PTIP-, REV1-and REV3-independent manner. Unanticipated, MAD2L2-depleted Rif1 2/2 MEFs showed an increased background of chromosome end fusion caused by telomere association between sister chromatids ( Fig. 4a and Extended Data Fig. 6d, e ). The molecular nature of these sister telomere associations remains to be determined, but they occur irrespective of TRF2 inhibition and potentially reflect replication problems 27 .
To address the dependencies for MAD2L2 function in DNA repair further, we investigated the requirements for MAD2L2 accumulation to DSBs and NHEJ activity at telomeres. Both DSB accumulation and the ability to promote telomere-driven genomic instability by MAD2L2 require an intact HORMA domain and carboxy terminus, while potential S/TQ (Ser or Thr residues that precede Gln) phosphorylation on Thr 103 appears dispensable ( Fig. 4b and Extended Data Fig. 7 ). Interestingly, while MAD2L2 accumulation to irradiation-induced DDR foci (IRIFs) was independent of PTIP or interaction of MAD2L2 with REV1 or REV3, it clearly depended on ATM kinase activity, RNF8, RNF168, 53BP1 and RIF1 ( Mad2l2 sh: 
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that promote RIF1 IRIFs, while those that promote PTIP IRIFs were dispensable [21] [22] [23] [24] (Fig. 4f , g and Extended Data Fig. 9a-c) . Similarly, MAD2L2 localization to uncapped telomeres required 53BP1 (Extended Data Fig. 8e ). In line with dependency on RIF1, whose localization to DSBs is strongly reduced in G2, MAD2L2 foci were also diminished in G2, although less than RIF1 foci ( Fig. 4h and Extended Data Fig. 9d ). The latter could relate to a proposed role for MAD2L2 in the late steps of HDR 28 .
In addition to inhibiting end resection, 53BP1, but not RIF1, promotes NHEJ by increasing mobility of uncapped telomeres 13, 20 . Consistent with MAD2L2 acting via end resection control downstream of RIF1, MAD2L2 deficiency did not impair mobility of uncapped telomeres (Extended Data Fig. 10a-c) .
Altogether, our data identify MAD2L2 as an important regulator of DNA repair pathway choice that promotes NHEJ at telomeres and DSBs in multiple settings, by inhibiting CTIP-and EXO1-dependent 59 end resection downstream of RIF1 (Extended Data Fig. 10d ). Whether MAD2L2 affects regulatory acetylation or phosphorylation of CTIP 18 , or blocks other end resection factors, awaits further investigation.
MAD2L2 and REV3 together compose Polf and act with REV1 in translesion synthesis to facilitate DNA replication past blocking lesions 4 . On the basis of reduced gene conversion and impaired RPA foci, RAD51 foci and DSB resolution in REV1-and Polf-depleted cells, it has been proposed that the ability of REV1/Polf to alleviate replication stalling might also be important during HDR synthesis 28 . Although requiring further characterization, together with the data presented here, this suggests differential roles for MAD2L2 in DSB repair. As shown here, MAD2L2 acts downstream of 53BP1/RIF1 in a REV1/REV3-independent manner to promote NHEJ by inhibiting resection, mostly in G1. In addition, MAD2L2, as part of Polf, might promote HDR by facilitating replication of damaged DNA formed after resection in G2.
The contribution of MAD2L2 to DNA repair at uncapped telomeres and DSBs suggests that aberrant MAD2L2 expression could have pathological consequences by compromising genome integrity. In this respect it is interesting that in particular MAD2L2, more than REV1 or REV3, is reported to be overexpressed in several cancers and has prognostic significance (ref. 29 and the Oncomine database). Furthermore, our finding that MAD2L2 is essential for CSR identifies MAD2L2 as a potential disease-susceptibility gene for human primary immunodeficiencies.
Online Content Methods, along with any additional Extended Data display items and Source Data, are available in the online version of the paper; references unique to these sections appear only in the online paper.
METHODS
TIGIR screen. Trf2 2/2 p53 2/2 TRF2ts MEFs (in short TRF2ts MEFs) were infected in triplicate with PLKO lentiviral shRNA pools consisting of 1,976 shRNAs selected from the Mouse TRC 1.0 Collection. Cells were infected with a multiplicity of infection below 1 and drug selected on 4 mg ml 21 puromycin. After completion of selection, TRF2ts MEFs were plated in duplicate on 15-cm dishes at 150,000 cells per dish and allowed to adhere at 32 uC. One set of plates was kept at 32 uC for 4 additional days, the other set of plates was subjected to 12 days of telomere uncapping at 39 uC, followed by recovery for 4 additional days at 32 uC. Cells were collected for genomic DNA isolation using a DNeasy Blood & Tissue Kit (Qiagen) and shRNA inserts were recovered from genomic DNA by 2 sequential PCR amplifications (PCR1 and PCR2). In PCR1 6 individual PCR reactions were performed on 325 ng genomic DNA using for each sample a common reverse primer P7_PLKO1_R (59-CAAGCAGAAGACGGCATACGAGATTTCTTTCCCCTGCACTGTACCC-39) and 1 of 6 forward primers with a unique index (underlined): Illuseq_01_PLKO1_f (59-ACACTCTTTCCCTACACGACGCTCTTCCGATCTCGTGATCTTGTGG AAAGGACGAAACACCGG-39), Illuseq_02_PLKO1_f (59-ACACTCTTTCCCT ACACGACGCTCTTCCGATCTACATCGCTTGTGGAAAGGACGAAACACC GG-39), Illuseq_03_PLKO1_f (59-ACACTCTTTCCCTACACGACGCTCTTCCG ATCTGCCTAACTTGTGGAAAGGACGAAACACCGG-39), Illuseq_04_PLKO1_f (59-ACACTCTTTCCCTACACGACGCTCTTCCGATCTTGGTCACTTGTGG AAAGGACGAAACACCGG-39), Illuseq_05_PLKO1_f (59-ACACTCTTTCCCT ACACGACGCTCTTCCGATCTCACTGTCTTGTGGAAAGGACGAAACACC GG-39), Illuseq_06_PLKO1_f (59-ACACTCTTTCCCTACACGACGCTCTTCC GATCTATTGGCCTTGTGGAAAGGACGAAACACCGG-39). In PCR2, 2.5 ml DNA from each PCR1 reaction was amplified using primers P5_Illuseq (59-AAT GATACGGCGACCACCGAGATCTACACTCTTTCCCTACACGACGCTCTT CCGATCT-39) and P7 (59-CAAGCAGAAGACGGCATACGAGAT-39). PCR products were pooled per condition, purified using a Qiagen PCR purification kit (Qiagen), analysed on a bioanalyzer for quality and concentration, and subjected to deep-sequencing on a Illumina Hiseq2000 genome analyser at the NKI Genomics Core Facility. Cell culture, growth assays, flow-cytometry. Trf2 2/2 p53 2/2 TRF2ts MEFs (TRF2ts MEFs) and Trf2 2/2 p53 2/2 Lig4 2/2 TRF2ts MEFs (TRF2ts Lig4 2/2 MEFs) were generated from Trf2 flox/2 p53 2/2 MEFs and Trf2 flox/2 p53 2/2 Lig4 2/2 MEFs as described before 11 . All cells were grown in DMEM with 100 U penicillin, 0.1 mg ml 21 streptomycin, 2 mM L-glutamine and 10% FBS. TRF2ts MEFs were maintained at the permissive temperature of 32 uC and only grown at 37 uC or 39 uC to induce telomere uncapping through inactivation of TRF2. All other cells were grown at 37 uC. Wildtype, 53bp1 2/2 , Rif1 2/2 , Ptip 1/1 and Ptip 2/2 MEFs were SV40 immortalized.
For colony survival assays, TRF2ts MEFs were plated at 150,000 cells per 15-cm dish or 45,000 per 10-cm dish, allowed to adhere and kept at 32 uC or placed at 39 uC. To evaluate potential toxicity or growth rate differences, plates were fixed with 10% formalin and stained with 0.1% crystal violet after growth for 1 week at 32 uC. To evaluate survival upon prolonged telomere uncapping plates were fixed and stained after growth for 12 days at 39 uC, followed by 0 or 2 weeks recovery at 32 uC. Quantifications of survival assays reflect the relative survival after growth for 12 days at 39 uC and 2 weeks recovery at 32 uC, corrected for plating efficiency and growth at 32 uC and assessed by crystal violet extraction as described below.
To address cell survival under telomere uncapping conditions in short-term growth assays, TRF2ts MEFs were plated in quadruplicate at 5,000 cells per well on a 12-well plate (Fig. 1c ) or in duplicate at 2,500 cells per well on a 24-wells plate (Extended Data Fig. 5h ), allowed to adhere overnight at 32 uC and then placed for 12-14 days at 39 uC. During this time period of non-permissive temperature, plates were fixed every 2-4 days with 10% formalin and stained with 0.1% crystal violet. Crystal violet was extracted from the plates using 10% acetic acid and its absorbance at 595 nm was quantified using a Tecan microplate reader. Quantifications were corrected for plating efficiency.
Cell cycle distribution of TRF2ts MEFs with or without MAD2L2 knockdown was determined by propidium iodide staining, as well as by BrdU incorporation, and acquired on a BD Fortessa using FACSDiva software (BD Biosciences) and analysed with FlowJo (TreeStar) software.
Analysis of tetraploidy (8N) and aneuploidy (.4N) was based on DNA-content analysis by flow cytometry of TRF2ts cells grown at 32 uC or 39 uC for 48 h and then stained with propidium iodide.
Cell cycle synchronisation was done as follows. For G1 cells, RPE cells were kept in 2.5 mM thymidine (T1895, Sigma) for 16 h, released for 6 h, treated with 10 mM RO3306 (Calbiochem) for 16 h. Synchronised cells were released for 1 h, mitotic cells were collected by mitotic shake off and replated to let them continue into G1 3.5 h before irradiation.
For G2 cells, RPE cells were kept in 2.5 mM thymidine for 16 h, released for 6 h and treated with 2.5 mM thymidine for 16 h. Synchronised cells were released for 4.5 h before irradiation to let cells progress to G2.
Plasmids. Cells were transduced as before 11 For knockdown of Ctip and Exo1 TRF2ts MEFs were transduced as before 11 with pRetroSuper-blas shRNA retroviruses containing the following target sequences: Ctip sh1: 59-GCAAGGTTTACAAGTCAAAGT-39, Ctip sh2: 59-GCAGACCTT TCTCAGTATA-39, Ctip sh3: 59-GCATTAACCGGCTACGAAA-39, Exo1 sh1: 59-GCATTTGGCACAAGAATTA-39. Retroviral shRNAs used for knockdown of Rnf8, Lig4 or TRF2 have been described before 11 . The 53bp1 shRNA vector used in CSR assays was obtained from Origene (FI334760) and contained the following target sequence: 59-GGAAGTTGAAACCAGTGTGATTAGTATTG-39.
For localization and complementation experiments human MAD2L2 complementary DNA was Gateway-cloned (Invitrogen) into pMSCV-retroviral vectors containing coding sequences for amino-terminal Flag or GFP epitopes. MAD2L2 deletion constructs were generated through Gateway-cloning (Invitrogen). The target sequences of Mad2l2 sh4 or the human MAD2L2 shRNA were changed to 59-GATTTTTCAGAAACGCAAGAA-39 or 59-TCCCGAACTGAATCAGTATA T-39, respectively, to create RNAi-resistant epitope-tagged MAD2L2 RR in pMSCV. GFP-RIF1, Flag-53BP1-DB and PTIP-GFP expression vectors were described before 23, 24 . The target sequence of the human RIF1 shRNA was changed to 59-GCA GCGAAGTTGAAACTTGAA-39 to create RNAi-resistant GFP-RIF1. Immunoblotting. Whole-cell lysates were prepared by scraping cells in SDS sample buffer; protein concentration was determined by standard BCA protein assay (Pierce) and equal amounts of protein were separated on precast 4-12% Bis-Tris or 3-8% Tris-acetate gels (Invitrogen). Immunoblotting was done according to standard methods using IRDye800CW-and IRDye680-labelled secondary antibodies for detection on the Odyssey Infrared imager (LI-COR) or using horseradish peroxidase (HRP)-conjugated secondary antibodies for detection by enhanced chemiluminescence (Supersignal, Thermo Scientific). Primary antibodies used were against MAD2L2 (sc135977, Santa Cruz, 1:500), phospho-ATM S1981 (4526, Cell Signaling, 1:1,000), phospho-KAP1 S824 (Bethyl, 1:1,000) , 53BP1 (NB100-305, Novus, LETTER RESEARCH 1:500), phospho-H2AX S139 (clone JBW301, Upstate, 1:1,000), CHK2 (611570, BD, 1:1,000), phospho-CHK1 S345 (2348, Cell Signaling, 1:1,000), phospho-ATR S428 (Cell Signaling, 1:1,000); RPA34 (RPA34-20, Gene Tex, 1:1,000); phospho-RPA32 S4/S8 (A300-245A, Bethyl, 1:1,000); CTIP (sc22838, Santa Cruz, 1:500); c-tubulin (GTU-88, Sigma, 1:5,000); b-catenin (610154, BD Biosciences, 1:2,000); GFP (a-11122, Invitrogen, 1:500); RIF1 (sc55979, Santa Cruz, 1:1,000); PTIP (ABE69, Millipore and ab2614, Abcam, 1:500); actin (CP01, Calbiochem, 1:5,000). Immunoblotting for tubulin, b-catenin or actin served as loading controls. Immunofluorescence. For immunofluorescence, cells were grown on 8-well chamber slides (Lab-Tek) and in cases of MAD2L2 detection first pre-extracted for 30 s to 5 min with 0.5% Triton/PBS on ice, then fixed for 10 min in 4% paraformaldehyde in PBS. Cells were permeabilized for 5 min (MEFs) or 10 min (U2OS) in 0.5% Triton/PBS, washed twice in PBS, incubated for 1 h in blocking solution (0.02% Triton, 5% NGS, 5% FCS in PBS) and overnight at 4 uC with primary antibodies in blocking solution. Immunofluorescence for PTIP-GFP in U2OS was done as described 24 . Primary antibodies used were against phospho-ATM S1981 (4526, Cell Signaling, 1:1,000), phospho-H2AX Ser 139 (05-636, Millipore and 2577S, Cell Signaling, 1:500), 53BP1 (A300-272A, Bethyl, 1:2,000), mRIF1 (gift from R. Chapman, 1:500) 22 , RIF1 (A300-569A, Bethyl, 1:1,000), MAD2L2 (sc135977, Santa Cruz, 1:100), Flag (F3165 or F1804 at 1:500, F7425 at 1:400, Sigma), GFP (a-11122, Invitrogen, 1:500). Cells were washed three times with 0.02% Triton/PBS, followed by incubation with Alexa Fluor 488 or 568 goat anti-mouse or anti-rabbit IgG secondary antibodies (Invitrogen) in blocking solution for 1 h. After four washes in 0.02% Triton/PBS, slides were mounted in Vectashield (Vector Laboratories) containing DAPI. Confocal fluorescence images were obtained on a Leica SP5 confocal system equipped with an Ar, Kr and HeNe laser system. Images were taken with a 363 NA 1.32 oil objective and standard LAS-AF software. Possible crosstalk between fluorochromes was avoided by careful selection of imaging conditions. A minimum of 100 cells per condition per experiment was analysed. DDR foci in MEFs were captured using the Metafer4/MetaCyte platform (MetaSystems) equipped with an AxioImager Z2 microscope (Carl Zeiss). Images of random selections of cells were acquired with an EC 'Plan-Neofluar' 340/0.75 objective. Analysis was done using MetaCyte software, carefully fine-tuned for each antibody. A minimum of 500 cells was analysed per condition per experiment for p-ATM, cH2AX, 53BP1 and RIF1. All assessments of irradation-induced DDR foci were done 3 h after irradiation with 5 Gy, with the exception of Fig. 3a , which is 30 min after 10 Gy. Metaphase chromosome analysis. Cell collection, preparation of metaphase spreads and telomere FISH with a FITC-OO-(CCCTAA) 3 peptide nucleic acid custom probe (Biosynthesis) for metaphase chromosome analysis was done as described 5 .
Digital images of metaphases were captured using the Metafer4/MSearch automated metaphase finder system (MetaSystems) equipped with an AxioImager Z2 microscope (Carl Zeiss). After scanning metaphase preparations at 310 magnification, high-resolution images of metaphases were acquired using a 'Plan-Apochromat' 363/1.40 oil objective. Chromosome fusions were quantified from .30 metaphases.
For monitoring mitotic telomeres by PNA FISH, IMR90 (E6/E7) cells were transduced with pMX-Flag-53BP1 (1-1711) or its mutant Thr1608Ala/Ser1618Ala (TASA) and pMX-GFP-RNF8 or its mutant Thr198Ala and selected with 0.2 mg ml 21 puromycin, for 3 days before plating. Cells were transfected with siRNAs targeting endogenous RNF8 (ThermoFisher, D-006900-01, target sequence: 59-AGAAUG AGCUCCAAUGUAUUU-39) and 53BP1 (ThermoFisher, D-003548-01, target sequence: 59-GAGAGCAGAUGAUCCUUUA-39) and the following siRNAs: PTIP siRNA pool (ThermoFisher, D-012795-01-0010, target sequences: 59-UUAAAG CGAGCAAGUAUUA-39, 59-GAGCCUGGGUUGAUUAACU-39, 59-GUUGA UGAGUAUAAGACUA-39 and 59-GCCAAUGCAGUGCUGUUUA-39), RIF1 (ThermoFisher, D-027983-02, target sequence: 59-AGACGGUGCUCUAUUGU UA-39), MAD2L2 (ThermoFisher, D-003272-10: 59-GAGAAAUUCGUCUUUG AGA-39) and non-targeting control siRNA (ThermoFisher, D-001210-02, target sequence: 59-UAAGGCUAUGAAGAGAUAC-39) using RNAiMax (Invitrogen) and synchronized with a double-thymidine block. Cells were subsequently processed as previously described 16 .
Pulsed-field gel electrophoresis and in-gel detection of telomeric DNA. Analysis of 39 single-stranded G-overhangs at mouse telomeres was performed as described 5 by pulsed-field gel electrophoresis and in-gel hybridization of a 32 P-labelled telomeric repeat (CCCTAA) 4 oligonucleotide to native DNA. In brief, Trf2 2/2 p53 2/2 TRF2ts MEFs were collected at the permissive temperature as well as after growth at the non-permissive temperature. Agarose plugs were prepared containing 1 3 10 6 cells per plug and digested overnight with 1 mg ml 21 proteinase K at 50 uC. Before loading on a 1% agarose gel, plugs were digested overnight with 60 U of MboI enzyme per plug. After running the gel on a CHEF-DR III pulsed-field gel electrophoresis system (BioRad), the gel was dried, pre-hybridized in Church Mix containing 7% SDS and hybridized overnight with a 32 P-labelled (CCCTAA) 4 probe, all under non-denaturing conditions. Signal was captured on a phosphorimager and analysed with AIDA Image Analyzer software. To confirm that the G-overhang signal detected with this method was indeed derived from 39 single-stranded telomeric TTAGGG repeats, digestion with 39 exonuclease and hybridization with a 32 P-labelled (TTAGGG) 4 probe specific for the C-rich strand was performed on separate plugs. After capturing the hybridization signal from single-stranded telomeric DNA, the gel was denatured and re-hybridized with the same probes to obtain a total telomere signal for the purpose of quantification. Repair and clonogenic survival assays. To quantify the repair of DSBs by NHEJ, U2OS cells transduced with shRNAs were transfected with pEJ5-GFP (NHEJ), as well as an mCherry expression vector and pCAGGS-Isce-I-Trex2 (ref. 30). Transfections were done using Mirus TransIT LT-1 (Mirus Bio LLC). The fraction of mCherry-positive cells that was GFP-positive was determined 72 h after transfection by flow-cytometry on a BD LSRFortessa using FACSDiva software. Quantification was carried out with FlowJo software (TreeStar).
For random plasmid integration assays 500,000 U2OS cells were seeded in 6-cm dishes 24 h before transfection with 3.9 mg of NdeI-linearized pMSCVblas-GFP and 0.1 mg of mCherry plasmids using ViaFect (Promega). Transfected cells were trypsinized the following day and seeded in 10-cm dishes at different densities for colony formation. Selection was initiated the following day with blasticidin at 5 mg ml 21 . Cells were fixed with 4% paraformaldehyde 10-14 days after plating and stained with 0.1% crystal violet. Colony counting was performed on a Col-Count (Oxford Optronix) and values were normalized for plating and transfection efficiencies.
For clonogenic survival assays U2OS cells were seeded in duplicate in 6-well plates at 100, 200 and 400 cells per well for unirradiated cells, and at 400, 800 and 1,600 cells per well for irradiated cells. Cells were grown for ,20 h before c-irradiation and then fixed after 10-12 days of recovery with 4% paraformaldehyde and stained with 0.1% crystal violet. Colonies with .50 cells were counted on a GelCount (Oxford Optronix) and the surviving fraction was determined. CSR assays. Research involving animals was performed in accordance with protocols approved by the animal facility at Toronto Centre for Phenogenomics (Toronto). Primary B cell extraction was performed as described before 23 . In brief, mature B lymphocytes were isolated from spleens of 8-12-week-old C57BL/6 mice by depletion of CD43 1 cells using CD43 microbeads (Miltenyi Biotech) according to the manufacturer's instructions. Purified B cells were resuspended at a concentration of 10 6 cells per ml in the presence of 25 mg ml 21 LPS (Sigma-Aldrich) to allow B cell proliferation. Both mouse CH12F3-2 (ref. 31) and primary B cells were infected with lentiviral/retroviral particles obtained from the supernatant of HEK293T cell cultures cotransfected with the lentiviral/retroviral shRNA constructs and the vector expressing MLV Gag-Pol (for retrovirus) or the lentiviral psPAX2 packaging vector with VSV-G envelope (2:1:1 ratio). In brief, the viral supernatant was concentrated at 25,000g for 90 min at 25 uC before resuspension in RPMI culture medium. Infection was subsequently performed as described 23 and followed by selection with puromycin.
IgM to IgA switching was assayed in CH12F3-2 cells activated with 1 ng ml 21 TGF-b1 (Preprotech), 10 ng ml 21 IL-4 (Preprotech) and 1 mg ml 21 agonist anti-CD40 (BD). IgA expression was measured by flow-cytometry using biotin-conjugated anti-mouse IgA antibody (1:200; eBioscience) followed by an anti-biotin-APC antibody at 0, 24 and 48 h after activation. Proliferation of the different transduced CH12F3-2 cell lines was monitored using CFSE (Invitrogen) following the manufacturer's guidelines. CSR assays in both cell types were done in triplicate for every independent experiment.
Ex-vivo isotype switching to IgG1 in primary B cells was assayed by flowcytometry using an anti-IgG1-biotin (1:200; BD) followed by allophycocyanin (APC)-conjugated anti-biotin (Miltenyi Biotech) and 10 mg ml 21 propidium iodide 5 days after isolation.
For semiquantitative RT-PCR analysis of Aid mRNA, IgM and IgA germ-line transcripts total RNA was extracted with TRIzol (Invitrogen) and cDNA was synthesized by random priming using the Superscript III reverse transcriptase kit (Invitrogen). Mouse Aicda transcripts were amplified using oligonucleotides 59-G TGCCACCTCCTGCTCACTGG-39 and 59-TTCATGTAGCCCTTCCCAGGC-39. IgM (m) germ-line transcripts were amplified using oligonucleotides 59-AAAATG TCCGCTGGGCTAAG-39 and 59-AGAACAGTCCAGTGTAGGCAGTAGA-39, IgA (Ia) using 59-CCTGGCTGTTCCCCTATGAA-39 and 59-GAGCTGGTGGG AGTGTCAGTG-39; and Gapdh transcripts were amplified using oligonucleotides 59-AGCCTCGTCCCGTAGACAA-39 and 59-AATCTCCACTTTGCCACTGC-39. 53BP1 depletion is known to impair CSR 3 and was included as control. TSCE. TSCE were detected by chromosome-orientation FISH, essentially as described 32 with minor modifications. In brief, for chromosome-orientation FISH cells were grown in 10 mM BrdU:BrdC (3:1) for 24 h with the addition of 0.2 mg ml 21 demecolcine for the final 2 h. Slides were treated with RNase A (0.5 mg ml 21 ) for 10 min at 37 uC, stained with Hoechst 33258 (0.5 mg ml 21 ) in 23 SSC for 15 min at room temperature and exposed to 5.4 3 10 3 J m 22 365-nm ultraviolet light RESEARCH LETTER (Stratalinker 2400 UV irradiator). Following digestion with exonuclease III (10 U ml 21 , Promega) for 10 min at room temperature, slides were dehydrated through an ethanol series (70%, 95% and 100%) and incubated sequentially with Cy3-TelG 59-[TTAGGG] 3 -39 and FITC-TelC 59-[CCCTAA] 3 -39 probes at room temperature. Telomere mobility. Telomere mobility analysis was done as described 13 with minor adjustments. TRF2ts cells expressing eGFP-TRF1 and mCherry-BP1-2 (53BP1 amino acids 1220-1711) were seeded on Willco wells and left to attach overnight at 32 uC. Before imaging, cells were incubated at 37 uC for 30 min in Leibovitz's L15 medium inside the Microscope climate chamber. Cells were monitored every minute for 20 min (t 5 20 frames) at 37 uC. Five-micrometre Z-stacks at 0.5-mm steps in both eGFP and mCherry channels were obtained with a 363 1.4 oil objective using ZEN software on an Observer Z1 microscope system (Carl Zeiss). Images were obtained at 2 3 2 binning with 512 3 512 pixels. Tracking of telomeres was performed with FIJI software, cells were registered with the Rigid body option from the StackReg plugin. Particles were then tracked with the particle detector and tracker plugin from Mosaic. Telomeres to track were selected on basis of colocalization with mCherry-BP1-2, and tracked for at least 17 out of 20 frames. Database. To address whether changes in MAD2L2 mRNA expression occur in human cancers we consulted the Oncomine database at https://www.oncomine. org/resource/login.html. Statistics. No statistical methods were used to predetermine sample size. P values were determined by Kruskal-Wallis ANOVA test. TIGIRs identifies independent shRNAs against Mad2l2 and the previously identified regulators of NHEJ-mediated telomere fusion Atm, Nbs1 (also known as Nbn), Rad50, 53bp1 and Rnf8. Listed are the independent shRNAs enriched .1.5-fold in at least two out of three TIGIR screens, with their average ratio of enrichment over all three screens. Ratios reflect shRNA abundance after 12 days of telomere uncapping at 39 uC followed by 4 days recovery at 32 uC versus shRNA abundance after growth for 4 days at 32 uC. b, Additional shRNAs targeting Mad2l2 or known TIGIRs that were enriched .1.5-fold in one out of three screens, with their ratio. Not shown are additional shRNAs against factors not previously implicated in control of telomere fusion, that were considerably enriched in these TIGIR screens but await validation. Fig. 1c . f, Photograph of shRNA-transduced TRF2ts cells grown for 12 days at 39 uC. Scale bar, 100 mm. g, None out of ten shRNAs targeting Rev1 or Rev3 were substantially enriched in any of three independent DDR TIGIR screens. h, shRNA-mediated Rev1 knockdown does not increase survival after prolonged telomere uncapping in survival assays of TRF2ts MEFs. Of note, Rev3 knockdown compromised viability and was therefore not informative in these assays. i, qRT-PCR analysis of mouse Rev1 expression levels of cells shown in h (error bars denote s.d.).
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